Max Schmulson

855 total citations
22 papers, 687 citations indexed

About

Max Schmulson is a scholar working on Gastroenterology, Surgery and Psychiatry and Mental health. According to data from OpenAlex, Max Schmulson has authored 22 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Gastroenterology, 8 papers in Surgery and 4 papers in Psychiatry and Mental health. Recurrent topics in Max Schmulson's work include Gastrointestinal motility and disorders (11 papers), Intestinal and Peritoneal Adhesions (4 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers). Max Schmulson is often cited by papers focused on Gastrointestinal motility and disorders (11 papers), Intestinal and Peritoneal Adhesions (4 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers). Max Schmulson collaborates with scholars based in Mexico, United States and Chile. Max Schmulson's co-authors include Bruce D. Naliboff, Emeran A. Mayer, Lin Chang, Lin Chang, Tony Lembo, Julie Munakata, Steve Fullerton, Eamonn M.M. Quigley, Erik Mayer and A. P. S. Hungin and has published in prestigious journals such as Gastroenterology, The American Journal of Medicine and The American Journal of Gastroenterology.

In The Last Decade

Max Schmulson

21 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Schmulson Mexico 10 615 251 198 112 93 22 687
WE Whitehead United States 7 745 1.2× 391 1.6× 168 0.8× 83 0.7× 125 1.3× 15 908
Lynne Hamm United States 11 554 0.9× 245 1.0× 259 1.3× 80 0.7× 94 1.0× 18 704
P. Rüegg Switzerland 4 653 1.1× 360 1.4× 210 1.1× 104 0.9× 65 0.7× 9 731
Brigitte Nault Switzerland 5 726 1.2× 450 1.8× 197 1.0× 97 0.9× 55 0.6× 8 781
Maria Eugenicos United Kingdom 10 405 0.7× 169 0.7× 106 0.5× 81 0.7× 45 0.5× 15 540
James Ritchie Argentina 6 609 1.0× 229 0.9× 249 1.3× 87 0.8× 112 1.2× 10 750
Priya Oka United Kingdom 4 444 0.7× 146 0.6× 119 0.6× 60 0.5× 58 0.6× 4 544
Minou Mayer United States 6 569 0.9× 213 0.8× 194 1.0× 97 0.9× 94 1.0× 10 801
Mopelola Adeyemo United States 8 396 0.6× 197 0.8× 140 0.7× 68 0.6× 50 0.5× 11 576
Susan E. Schneck United States 5 345 0.6× 112 0.4× 106 0.5× 59 0.5× 59 0.6× 7 407

Countries citing papers authored by Max Schmulson

Since Specialization
Citations

This map shows the geographic impact of Max Schmulson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Schmulson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Schmulson more than expected).

Fields of papers citing papers by Max Schmulson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Schmulson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Schmulson. The network helps show where Max Schmulson may publish in the future.

Co-authorship network of co-authors of Max Schmulson

This figure shows the co-authorship network connecting the top 25 collaborators of Max Schmulson. A scholar is included among the top collaborators of Max Schmulson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Schmulson. Max Schmulson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sperber, Ami D., Tamar Freud, Imran Aziz, et al.. (2021). Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life. Clinical Gastroenterology and Hepatology. 20(5). e945–e956. 86 indexed citations
2.
Valenzuela, Jorge, Jorge Alvarado, Henry Cohen, et al.. (2019). Latin-American consensus document on irritable bowel syndrome Un consenso latinoamericano sobre el síndrome del intestino irritable. Universidad de Chile.
3.
Quigley, Eamonn M.M., Michael Fried, Kok‐Ann Gwee, et al.. (2016). World Gastroenterology Organisation Global Guidelines Irritable Bowel Syndrome. Journal of Clinical Gastroenterology. 50(9). 704–713. 92 indexed citations
4.
Remes-Troche, J.M., et al.. (2013). [Guidelines for diagnosis and treatment of constipation in Mexico. A) Epidemiology (meta-analysis of the prevalence), pathophysiology and classification].. PubMed. 76(2). 126–32. 8 indexed citations
5.
Quigley, Eamonn Martin, Michael Fried, Kok‐Ann Gwee, et al.. (2009). World Gastroenterology Organisation Global Guideline: Irritable bowel syndrome: A global perspective - April 20, 2009. 7(3). 23–30. 5 indexed citations
6.
Schmulson, Max, et al.. (2005). Seroprevalence of IgA Antibodies to Tissue Transglutaminase in a University-Based Population Study in Mexico City. The American Journal of Gastroenterology. 100. S96–S96. 5 indexed citations
7.
Valenzuela, Jorge E., Jorge Alvarado, Henry Cohen, et al.. (2004). Un consenso latinoamericano sobre el síndrome del intestino irritable. Gastroenterología y Hepatología. 27(5). 325–343. 25 indexed citations
8.
Hinojosa, Carlos A., et al.. (2004). [Impact of gastrointestinal symptoms on health related quality of life in patients with type 2 diabetes mellitus].. PubMed. 55(6). 594–9. 9 indexed citations
9.
Schmulson, Max, et al.. (2003). [Differences in the stress symptoms rating scale in Spanish between patients with irritable bowel syndrome (IBS) and healthy controls].. PubMed. 67(3). 161–5. 8 indexed citations
10.
Aréchigá, Hugo, et al.. (2002). Síndromes clínicos frecuentes sin bases anatómicas. Nuevas perspectivas sobre la fibromialgia y el intestino irritable. Gaceta Médica de México. 138(1). 41–56. 1 indexed citations
11.
Valdovinos, Miguel A., et al.. (2001). Irritable Bowel Syndrome in Mexico. Digestive Diseases. 19(3). 251–257. 17 indexed citations
12.
Schmulson, Max, et al.. (2000). Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients. The American Journal of Gastroenterology. 95(1). 152–156. 62 indexed citations
13.
Schmulson, Max & Lin Chang. (1999). Diagnostic approach to the patient with irritable bowel syndrome. The American Journal of Medicine. 107(5). 20–26. 35 indexed citations
14.
Lee, O. Y., Max Schmulson, & Emeran A. Mayer. (1999). Common functional gastrointestinal disorders: Nonulcer dyspepsia and irritable bowel syndrome. Clinical cornerstone. 1(5). 57–71. 10 indexed citations
15.
Lembo, Tony, Bruce D. Naliboff, Julie Munakata, et al.. (1999). Symptoms and Visceral Perception in Patients With Pain-Predominant Irritable Bowel Syndrome. The American Journal of Gastroenterology. 94(5). 1320–1326. 170 indexed citations
16.
Schmulson, Max, et al.. (1999). Symptom Differences in Moderate to Severe Ibs Patients Based on Predominant Bowel Habit. The American Journal of Gastroenterology. 94(10). 2929–2935. 118 indexed citations
17.
Chang, Lin, J. Munakata, D.H.S. Silverman, et al.. (1998). Differences in left prefrontal activation to visceral and somatic stimuli assessed by O-15-water PET in female patients with irritable bowel syndrome (IBS) and fibromyalgia. Gastroenterology. 114. A732–A732. 3 indexed citations
18.
Naliboff, Bruce D., D.H.S. Silverman, J. Munakata, et al.. (1998). Altered regional brain activity to rectal distenstion following repetitive sigmoid stimulation in IBS. Gastroenterology. 114. A809–A809. 1 indexed citations
19.
Chang, Lin, Emeran A. Mayer, J. Munakata, et al.. (1998). The coexistence of fibromyalgia (FM) alters rectal perception before and after sigmoid stimulation in female IBS patients. Gastroenterology. 114. A732–A732. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026